Drug Resistance Hampers Our Capacity to Roll Back Malaria
Open Access
- 15 August 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (s4) , S247-S257
- https://doi.org/10.1086/430785
Abstract
Widespread drug resistance in parasites aggravates the burden of malaria. The extent of the problem is due mainly to the limited armamentarium of druKeywords
This publication has 52 references indexed in Scilit:
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Artemisinin‐based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South AfricaTropical Medicine & International Health, 2004
- The global distribution and population at risk of malaria: past, present, and futureThe Lancet Infectious Diseases, 2004
- Estimating the needs for artesunate-based combination therapy for malaria case-management in AfricaTrends in Parasitology, 2003
- Combating malaria in AfricaTrends in Parasitology, 2002
- Combination Therapy for MalariaDrugs, 2002
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001
- Modelling a Predictable Disaster:Parasitology Today, 2000
- New insights into the epidemiology of malaria relevant for disease controlBritish Medical Bulletin, 1998
- Quinine in severe falciparum malaria: evidence of declining efficacy in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994